Value of neutrophil-to-lymphocyte ratio in predicting surgical intervention for hydronephrosis during pregnancy.

Hydronephrosis neutrophil to lymphocyte ratio platelet to lymphocyte ratio pregnancy ureteral stones

Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
May 2023
Historique:
medline: 14 6 2023
pubmed: 25 11 2022
entrez: 24 11 2022
Statut: ppublish

Résumé

We aimed to examine the hematological parameters of pregnant patients with ureteral stones that require intervention. Medical data of patients presenting to urology department between October 2018 and December 2020 were retrospectively analyzed. Patients with flank pain associated with hydronephrosis were included in the study and divided into two groups according to whether an intervention was performed or not (Group-1, Group-2). Ureterorenoscopy (URS) or ureteral stent placement was performed as intervention. Demographic data, complete blood count (CBC), urine analysis, and ultrasonographic findings were collected. Gestational age (week), number of pregnancies, maternal age (years), Anteroposterior pelvis diameter (mm), VAS (Visual Analog Scale) (range 1-10) and mean platelet volume (MPV) were collected from the patient file. Inflammatory markers including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were computed. About 35 patients were included in Group-1 and 52 patients in Group-2. Ureterorenoscopy was performed in 21/35 (60%) patients, and ureteral stents were placed in 14/35 (40%) patients. None of the patients experienced complications. There was no statistical difference between these two groups in terms of maternal age, gestational age, number of pregnancies, pelvis diameter, PLR, and MPV. VAS and NLR were statistically higher in group-1 ( We think that NLR can be used to determine the group that needs to be intervented due to ureteral stones in patients with symptomatic hydronephrosis during pregnancy.

Sections du résumé

BACKGROUND UNASSIGNED
We aimed to examine the hematological parameters of pregnant patients with ureteral stones that require intervention.
METHODS UNASSIGNED
Medical data of patients presenting to urology department between October 2018 and December 2020 were retrospectively analyzed. Patients with flank pain associated with hydronephrosis were included in the study and divided into two groups according to whether an intervention was performed or not (Group-1, Group-2). Ureterorenoscopy (URS) or ureteral stent placement was performed as intervention. Demographic data, complete blood count (CBC), urine analysis, and ultrasonographic findings were collected. Gestational age (week), number of pregnancies, maternal age (years), Anteroposterior pelvis diameter (mm), VAS (Visual Analog Scale) (range 1-10) and mean platelet volume (MPV) were collected from the patient file. Inflammatory markers including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were computed.
RESULTS UNASSIGNED
About 35 patients were included in Group-1 and 52 patients in Group-2. Ureterorenoscopy was performed in 21/35 (60%) patients, and ureteral stents were placed in 14/35 (40%) patients. None of the patients experienced complications. There was no statistical difference between these two groups in terms of maternal age, gestational age, number of pregnancies, pelvis diameter, PLR, and MPV. VAS and NLR were statistically higher in group-1 (
CONCLUSIONS UNASSIGNED
We think that NLR can be used to determine the group that needs to be intervented due to ureteral stones in patients with symptomatic hydronephrosis during pregnancy.

Identifiants

pubmed: 36420819
doi: 10.1177/03915603221135319
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

365-370

Auteurs

Muammer Bozkurt (M)

Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Kamil Gokhan Seker (KG)

Department of Urology, Mus State Hospital, Mus, Turkey.

Mustafa Erkoc (M)

Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Eyyup Danis (E)

Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Osman Can (O)

Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Recep Burak Degirmentepe (RB)

Department of Urology, Sakarya University Training and Research Hospital, Sakarya, Turkey.

Halil Lütfi Canat (HL)

Department of Urology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH